SMTL ID : 4nwm.2 (1 other biounit)

Crystal structure of Bruton agammaglobulinemia tyrosine kinase complexed with BMS-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

monomer

Ligands

1 x 2P5: 4-tert-butyl-N-[2-methyl-3-(6-{[4-(morpholin-4-ylcarbonyl)phenyl]amino}-7H-purin-2-yl)phenyl]benzamide(Non-covalent)

2P5.1: 24 residues within 4Å: Chain A: L.14, G.15, T.16, G.17, Q.18, F.19, V.22, A.34, K.36, T.80, E.81, Y.82, M.83, A.84, N.85, G.86, D.127, N.132, L.134, D.145, L.148, S.149, V.152, Y.157 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.14, A:F.19, A:V.22, A:V.22, A:V.22, A:Y.82, A:D.127, A:L.148, A:V.152, A:Y.157 Hydrogen bonds: A:T.80, A:T.80, A:M.83, A:M.83 Water bridges: A:G.17

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shi, Q. et al., Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases. Bioorg.Med.Chem.Lett. (2014)

Release Date

2014-04-02

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence